Pirarubicin is an analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. It is grouped under the following drug class(es): Anthracyclines and Cytotoxics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Adriamycin and tetrahydropyranyl. Its PubChem CID is 11296583.
Pirarubicin
| CAS No | 72496-41-4 |
|---|---|
| Molecular Formula | C32H37NO12 |
| Molecular Weight | 627.6 g/mol |
| Synonyms | (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pirarubicin is an analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis.
The listed CAS number is 72496-41-4.
The listed molecular formula is C32H37NO12.
The listed molecular weight is 627.6 g/mol.
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione.
The source lists Adriamycin and tetrahydropyranyl.